Abstract
The contrast-enhanced ultrasonography (US) study with intravenous administration of a contrast agent should be performed with the optimal technique under careful consideration of the characteristics of the contrast agent. In this chapter, we describe the contrast-imaging method using Levovist, the only contrast agent that has been approved under the Pharmaceutical Affairs Law in Japan.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Kudo M: Contrast harmonic ultrasound is a breakthrough technology in the diagnosis and treatment of hepatocellular carcinoma. J Med Ultrasonics 2001; 28:79–81
Wen YL, Kudo M, Minami Y, et al: Contrast-enhanced Agent Detection Imaging: preliminary study in hepatocellular carcinoma. J Med Ultrasonics 2003 (in press)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Japan
About this chapter
Cite this chapter
Kudo, M. (2003). Agent Detection Imaging (ADI) (Acuson Sequoia 512). In: Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-65904-4_13
Download citation
DOI: https://doi.org/10.1007/978-4-431-65904-4_13
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-65906-8
Online ISBN: 978-4-431-65904-4
eBook Packages: Springer Book Archive